Calcium-mediated myopathy at neuromuscular junctions of normal and dystrophic muscle
References (56)
- et al.
Commentary: lysosomotropic agents
Biochem. Pharmacol.
(1974) - et al.
Failure to protect frog skeletal muscle from ionophore-induced damage by the use of the protease inhibitor leupeptin
Comp. Biochem. Physiol.
(1979) Ultrastructural reactions in muscle disease
Med. Clin. North Am.
(1968)- et al.
Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes
Biochem. Biophys. Acta
(1980) - et al.
Ultrastructural changes at the motor end-plate produced by an irreversible cholinesterase inhibitor
Exp. Neurol.
(1975) - et al.
Initial ultrastructural abnormalities at the motor end-plate produced by a cholinesterase inhibitor
Exp. Neurol.
(1977) - et al.
Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain
Exp. Neurol.
(1976) - et al.
Increased calcium-activated neutral protease activity in muscles of dystrophic hamsters and mice
J. Neurol. Sci.
(1979) - et al.
The effect of acetylcholine on the function and structure of the developing mammalian neuromuscular junction
Neuroscience
(1980) - et al.
Muscular dystrophy and other myopathies: sarcotubular vesicles in early disease
Biochem. Med.
(1969)
Removal of Z-lines and α-actinin from isolated myofibrils by a calcium-activated neutral protease
J. Biol. Chem.
(1975)
Inhibition of lysosomal function in red and white skeletal muscles by chloroquine
Exp. Neurol.
(1981)
Inhibition of proteolytic activity of calcium-activated neutral protease by leupeptin and antipain
Biochem. Biophys. Res. Commun.
(1978)
Paraoxon-induced myopathy: muscle specificity and acetylcholine involvement
Exp. Neurol.
(1976)
Carbamylation of acetylcholinesterase
J. Biol. Chem.
(1960)
Structures and activities of protease inhibitors of microbial origin
Reversible necrosis at the end-plate region in striated muscles of the rat poisoned with cholinesterase inhibitors
Experientia
(1969)
Skeletal muscle lysosomes
Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies
Neurology (New York)
(1978)
Ca++ specific removal of Z-lines from rabbit skeletal muscle
J. Cell. Biol.
(1972)
Method for quantitative morphologic analysis of tissues
J. Natl. Cancer Inst.
(1943)
Some properties of a Ca++-activated protease that may be involved in myofibrillar protein turnover
A Ca++-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle
Biochemistry
(1976)
A Ca++-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme
Biochemistry
(1976)
Localization of a Ca2+-activated neutral protease in skeletal muscle
J. Cell Biol.
(1980)
Study of long-term anticholinesterase therapy effects on neuromuscular transmission and on motor end-plate fine structure
Neurology (New York)
(1973)
Therapeutic trials in muscular dystrophy. III. Studies of microbial proteinase inhibitors in murine dystrophy
Arch. Neurol.
(1977)
Chronic inhibition of cholinesterase as a cause of myopathy
Neurology (New York)
(1972)
Cited by (0)
- 1
This study was supported by two grants from the National Institutes of Health, NS09315 and GM 10422. The authors thank Mary Johnson and Marie Read for technical assistance and Steve Jones and Bruce Land for helpful advice.
Copyright © 1982 Published by Elsevier Inc.